Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7655)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2020 (publication date) through Apr 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Al-Dhamin Z, Liu LD, Li DD, Zhang SY, Dong SM, Nan YM. Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of in vivo studies. World J Gastroenterol 2020; 26(47): 7444-7469 [PMID: 33384547 DOI: 10.3748/wjg.v26.i47.7444] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i47/7444.htm |
| Number | Citing Articles |
| 1 |
Shouli Yuan, Meng Dong, Hanlin Zhang, Xiaoxiao Jiang, Chunlong Yan, Rongcai Ye, Huiqiao Zhou, Li Chen, Huiru Lian, Wanzhu Jin. Ginsenoside PPD inhibit the activation of HSCs by directly targeting TGFβR1. International Journal of Biological Macromolecules 2022; 194: 556 doi: 10.1016/j.ijbiomac.2021.11.098
|
| 2 |
Zerui Wang, Tiantian Li, Ziying Zhang, Mengqi Yuan, Ming Shi, Fu-Sheng Wang, En-Qiang Linghu, Lei Shi. Human umbilical cord-derived mesenchymal stem cells for the treatment of decompensated cirrhosis (MSC-DLC-1): a dose-escalation, phase I trial protocol. BMJ Open 2023; 13(12): e078362 doi: 10.1136/bmjopen-2023-078362
|
| 3 |
Ahmed Elzainy, Abir El Sadik, Waleed Mohammad Altowayan. Comparison between the Regenerative and Therapeutic Impacts of Bone Marrow Mesenchymal Stem Cells and Adipose Mesenchymal Stem Cells Pre-Treated with Melatonin on Liver Fibrosis. Biomolecules 2024; 14(3): 297 doi: 10.3390/biom14030297
|
| 4 |
Nathaly Enciso, José Amiel, Fredy Fabián-Domínguez, Jhon Pando, Nancy Rojas, Carlos Cisneros-Huamaní, Ernesto Nava, Javier Enciso, Ulises Urzua. Model of Liver Fibrosis Induction by Thioacetamide in Rats for Regenerative Therapy Studies. Analytical Cellular Pathology 2022; 2022: 1 doi: 10.1155/2022/2841894
|
| 5 |
María Martín-López, Cristina Rosell-Valle, Blanca Arribas-Arribas, Beatriz Fernández-Muñoz, Rosario Jiménez, Sonia Nogueras, Ana Belén García-Delgado, Fernando Campos, Mónica Santos-González. Bioengineered tissue and cell therapy products are efficiently cryopreserved with pathogen-inactivated human platelet lysate-based solutions. Stem Cell Research & Therapy 2023; 14(1) doi: 10.1186/s13287-023-03300-z
|
| 6 |
Jiejuan Lai, Shifang Jiang, Ling Shuai, Yujun Zhang, Renpei Xia, Quanyu Chen, Lianhua Bai. Comparison of the biological and functional characteristics of mesenchymal stem cells from intrahepatic and identical bone marrow. Stem Cell Research 2021; 55: 102477 doi: 10.1016/j.scr.2021.102477
|
| 7 |
Shouli Yuan, Meng Dong, Hanlin Zhang, Hongde Xu, Qi Wang, Chunlong Yan, Rongcai Ye, Xiaoxiao Jiang, Huiqiao Zhou, Li Chen, Jun Cheng, Wen Xie, Wanzhu Jin. Oral delivery of a Lactococcus lactis expressing extracellular TGFβR2 alleviates hepatic fibrosis. Applied Microbiology and Biotechnology 2021; 105(14-15): 6007 doi: 10.1007/s00253-021-11485-7
|
| 8 |
Liang Liu, Yanling Zhou, Xuchen Dong, Suwen Li, Shan Cheng, Haoran Li, Yongdong Li, Jiaqi Yuan, Liping Wang, Jun Dong, Xiaodong Li. HOTAIRM1 Maintained the Malignant Phenotype of tMSCs Transformed by GSCs via E2F7 by Binding to FUS. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/7734413
|
| 9 |
D. V. Garbuzenko. Current strategies for targeted therapy of liver fibrosis. Bulletin of Siberian Medicine 2022; 21(3): 154 doi: 10.20538/1682-0363-2022-3-154-165
|
| 10 |
Simona-Rebeca Nazarie (Ignat), Sami Gharbia, Anca Hermenean, Sorina Dinescu, Marieta Costache. Regenerative Potential of Mesenchymal Stem Cells’ (MSCs) Secretome for Liver Fibrosis Therapies. International Journal of Molecular Sciences 2021; 22(24): 13292 doi: 10.3390/ijms222413292
|
| 11 |
Asmaa R. Ellakany, Hanan El Baz, Zeinab S. Shoheib, Mohamed Elzallat, Dalia S. Ashour, Nabila A. Yassen. Stem cell-derived exosomes as a potential therapy for schistosomal hepatic fibrosis in experimental animals. Pathogens and Global Health 2023; : 1 doi: 10.1080/20477724.2023.2240085
|